HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma.

AbstractBACKGROUND:
Cancers of the bile duct and the pancreas are virtually indistinguishable using conventional histopathological and clinical characteristics. We sought to use microRNA (miR) profiling to differentiate these two cancers.
METHODS:
RNA was harvested from the tumors of patients undergoing curative resection for cholangiocarcinoma or pancreatic adenocarcinoma and compared with adjacent normal bile duct or pancreas, respectively. There were 31 pairs of cholangiocarcinoma with matched tumor and adjacent bile duct and nine pairs of pancreatic cancer with matched tumor and adjacent uninvolved pancreas that had sufficient quantity of RNA that were included in the final analysis. Differential microRNA expression profiles were determined using the nCounter System from nanoString Technologies (Seattle, WA,USA).
RESULTS:
A total of 41 differentially expressed miRs were identified in cholangiocarcinoma (25 overexpressed, 16 underexpressed) and 52 differentially expressed miRs were found in pancreatic adenocarcinoma (30 overexpressed, 22 underexpressed) relative to adjacent normal tissue. Of these two profiles, 15 miRs were commonly dysregulated between tumor types. Also, eight miRs were similarly overexpressed or underexpressed in cholangiocarcinoma and pancreatic adenocarcinoma, whereas the other seven miRs had inverse expression levels.
CONCLUSIONS:
Cholangiocarcinoma has a distinct miR profile from pancreatic adenocarcinoma. Discrimination between these two tumor types may be possible with as few as seven miRs.
AuthorsAmy L Collins, Sylwia Wojcik, James Liu, Wendy L Frankel, Hansjuerg Alder, Lianbo Yu, Thomas D Schmittgen, Carlo M Croce, Mark Bloomston
JournalAnnals of surgical oncology (Ann Surg Oncol) Vol. 21 Issue 1 Pg. 133-8 (Jan 2014) ISSN: 1534-4681 [Electronic] United States
PMID24046106 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers, Tumor
  • MicroRNAs
Topics
  • Adenocarcinoma (diagnosis, genetics)
  • Bile Duct Neoplasms (diagnosis, genetics)
  • Bile Ducts, Intrahepatic
  • Biomarkers, Tumor (genetics)
  • Cholangiocarcinoma (diagnosis, genetics)
  • Diagnosis, Differential
  • Gene Expression Profiling
  • Humans
  • MicroRNAs (genetics)
  • Oligonucleotide Array Sequence Analysis
  • Pancreatic Neoplasms (diagnosis, genetics)
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: